ENDRA Life Sciences Inc Total Liabilities
ENDRA Life Sciences Inc total liabilities. Based on the latest financial reports, ENDRA Life Sciences Inc (NDRA) has total liabilities worth $1.63 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See ENDRA Life Sciences Inc (NDRA) liquidity interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of ENDRA Life Sciences Inc (2014–2025)
Total liabilities of ENDRA Life Sciences Inc from 2014 to 2025. This chart illustrates how ENDRA Life Sciences Inc's total liabilities have evolved over time, based on quarterly financial data.
ENDRA Life Sciences Inc Competitors by Total Liabilities
The table below lists competitors of ENDRA Life Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vinvest Capital Holdings Bhd
KLSE:0069
|
Malaysia | RM45.56 Million |
|
Ictsi Jasa Prima Tbk
JK:KARW
|
Indonesia | Rp44.68 Million |
|
Sintex Plastics Technology Limited
NSE:SPTL
|
India | Rs206.50 Million |
|
NGS Group AB (publ)
ST:NGS
|
Sweden | Skr55.14 Million |
|
MAA Group Bhd
KLSE:1198
|
Malaysia | RM95.09 Million |
|
Smartiks Yazilim AS
IS:SMART
|
Turkey | TL107.22 Million |
|
Snipp Interactive Inc
V:SPN
|
Canada | CA$13.42 Million |
|
Baijiayun Group Ltd
NASDAQ:RTC
|
USA | $47.11 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down ENDRA Life Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ENDRA Life Sciences Inc balance sheet assets.
Liquidity & Leverage Metrics
ENDRA Life Sciences Inc Total Liabilities Ratios Explained
ENDRA Life Sciences Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ENDRA Life Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ENDRA Life Sciences Inc (2014–2025)
The table below shows the annual total liabilities of ENDRA Life Sciences Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.59 Million | -15.77% |
| 2024-12-31 | $1.89 Million | +72.76% |
| 2023-12-31 | $1.10 Million | -47.08% |
| 2022-12-31 | $2.07 Million | -0.99% |
| 2021-12-31 | $2.09 Million | +31.01% |
| 2020-12-31 | $1.60 Million | -33.94% |
| 2019-12-31 | $2.42 Million | +147.86% |
| 2018-12-31 | $974.58K | +14.90% |
| 2017-12-31 | $848.21K | -38.74% |
| 2016-12-31 | $1.38 Million | +485.62% |
| 2015-12-31 | $236.42K | +142.23% |
| 2014-12-31 | $97.60K | -- |
About ENDRA Life Sciences Inc
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fa… Read more